(Q33496118)
Statements
Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group (English)
J J Rusthoven
I C Quirt
N A Iscoe
P B McCulloch
K W James
R C Lohmann
J Jensen
S Burdette-Radoux
A J Bodurtha
H K Silver
S Verma
G R Armitage